Completed PHASE3 INTERVENTIONAL NCT01046656

L Reuteri for the Prevention of Nosocomial Diarrhea (PND)

Efficacy of Lactobacillus Reuteri DSM 17938 in the Prevention of Nosocomial Diarrhea in Children. Randomized Double-blind Placebo Controlled Trial

Sponsor: Medical University of Warsaw

Conditions Diarrhea Gastroenteritis Nosocomial Infection

Interventions Lactobacillus reuteri (DSM 17938)

Updated 5 times since 2017 Last updated: Jan 27, 2012 Started: Dec 31, 2009 Primary completion: Jun 30, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diarrhea and Gastroenteritis, this trial is completed. The trial is conducted by Medical University of Warsaw and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Warsaw

Data source: Medical University of Warsaw

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland